Towards a Saphenous Vein Graft Moratorium

Area of Science:

• Cardiovascular Surgery
• Interventional Cardiology
• Vascular Biology

Background:

• Saphenous vein grafts (SVGs) are commonly used in coronary artery bypass grafting (CABG) but are prone to atherosclerosis and failure.
• Percutaneous coronary interventions (PCIs) do not prevent atherosclerosis progression in SVGs.
• Native coronary arteries exhibit better long-term patency compared to SVGs.

Purpose of the Study:

• To compare the long-term efficacy of arterial grafts versus saphenous vein grafts in coronary revascularization.
• To evaluate the role of percutaneous revascularization in managing saphenous vein graft atherosclerosis.
• To determine optimal strategies for achieving long-lasting coronary revascularization in complex coronary artery disease.

Main Methods:

• Comparative analysis of graft patency and atherosclerosis progression in SVG and arterial grafts post-CABG.
• Assessment of outcomes for patients undergoing PCI on native coronary arteries versus SVGs.
• Review of long-term clinical data comparing different revascularization strategies.

Main Results:

• Atherosclerosis develops and progresses rapidly in SVGs after CABG.
• PCI does not halt SVG atherosclerosis progression, leading to frequent graft failure.
• Arterial grafts demonstrate significantly better long-term patency compared to SVGs.

Conclusions:

• Arterial grafts provide superior long-term outcomes in CABG for complex coronary artery disease.
• Combining surgical arterial grafting with PCI and drug-eluting stents may offer the best approach for durable coronary revascularization.
• Minimizing the use of SVGs is recommended for improved patient outcomes.